Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Nuala Trainor
Advertisement
Nuala Trainor is director of Biological Programs, Octane Biotech Inc.
Articles by Nuala Trainor
Advertisement
Latest Updated Articles
End-to-End Cell Therapy Automation: An Immunotherapy Case StudyPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
